I’m not sure I understood all of your points. But overall, yes, we might just get rid of rare mutations, but I wonder if realistically people will stop there. (That is indeed a slippery slope argument.)
I’m not sure I understood all of your points. But overall, yes, we might just get rid of rare mutations, but I wonder if realistically people will stop there. (That is indeed a slippery slope argument.)